Protocol for a Phase II-studyAnti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - a randomised, double-blinded, placebo-controlled, cross over study - Protocol for a Phase II-studyAnti-inflammatory pulmonal therapy of CF-patients with Amitriptyline an ...
Protocol for a Phase II-studyAnti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - a randomised, double-blinded, placebo-controlled, cross over study - Protocol for a Phase II-studyAnti-inflammatory pulmonal therapy of CF-patients with Amitriptyline an ...
CF-patients develop a chronic pulmonary infection with Pseudomonas aeruginosa (P. aeruginosa). At present it is unknown why CF-patients are highly sensitive to P. aeruginosa infections and, most important, no curative treatment for cystic fibrosis is available. This Study should provide a novel anti-inflammatory treatment for cystic fibrosis, which reduces pulmonary complications, progression of the disease and may possibly increase the life-expectance of the patients. CF-patients develop a chronic pulmonary infection with Pseudomonas aeruginosa (P. aeruginosa). At pr ...